Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,764.40
(
-0.13%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
104.78
(
0.33%
)
Bitcoin
70,458.96
(
0.80%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122802
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 56669

Tuesday, 12/25/2007 7:57:09 PM

Tuesday, December 25, 2007 7:57:09 PM

Post# of 257262
Question for BI, et al, re Protonix case:

If WYE were to launch an authorized generic, how would it affect the assessment of damages in the event WYE eventually prevails in the patent trial? Would an AG launch preclude collecting treble damages or lessen the likelihood of such to a significant degree? T.i.a. Dew

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now